Appeals Court Hands Victory To Merck

Law360, New York (November 20, 2007, 12:00 AM EST) -- A federal appeals court has nixed Apotex Corp.’s claims of fraud against Merck & Co. Inc. in a long-running patent dispute related to a blood pressure drug that has lasted more than a decade, affirming a lower court ruling in the case.

In a decision handed down Friday, the U.S. Court of Appeals for the Federal Circuit rejected Apotex’s arguments that Merck had made false statements and misrepresented facts in an earlier battle during the long-running legal war.

“We’re of course disappointed, we always knew it...
To view the full article, register now.